Hortensa Valeron, MD
Psychosomatic Medicine · Miami, FLNPI 1932427044
Payments from drug & device makers
Across 72 payments — averaging $31.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$511
- Otsuka America Pharmaceutical, Inc.$440
- Indivior Inc.$339
- Alkermes, Inc.$330
- Johnson & Johnson$303
- Teva Pharmaceuticals USA, Inc.$150
- plus $184 from 3 others
What the payments were for
- Food & beverage$1,775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $511 |
| Otsuka America Pharmaceutical, Inc. | 20 | $440 |
| Indivior Inc. | 13 | $339 |
| Alkermes, Inc. | 15 | $330 |
| Johnson & Johnson | 10 | $303 |
| Teva Pharmaceuticals USA, Inc. | 6 | $150 |
| Lundbeck LLC | 1 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$107
How this compares
Too few psychosomatic medicine providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 134 | $710 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $385 |
| Quetiapine Fumarate | 25 | $334 |
| Escitalopram Oxalate | 50 | $190 |
| Duloxetine Hcl | 29 | $166 |
| Memantine Hcl | 31 | $166 |
| Donepezil Hcl | 29 | $105 |
| Clonazepam | 31 | $101 |
| Trazodone Hcl | 68 | $101 |
| Bupropion Hcl SrBupropion Hcl | 19 | $88 |
| Hydroxyzine Hcl | 14 | $80 |
| Fluoxetine Hcl | 21 | $74 |
| Bupropion XlBupropion Hcl | 18 | $70 |
| Citalopram HbrCitalopram Hydrobromide | 24 | $64 |
| Buspirone Hcl | 22 | $60 |
Paid to pharmacies, not to this prescriber.
Other psychosomatic medicine in Miami
- Dominique MusselmanMiami$49
- Constanza Martinez PinanezMiami$17
- Mencia Gomez DevargasHollywood$288K
- Clara Alvarez VillalbaHallandale Beach$3K
- Nancy ChiarelloAtlantic Beach$135
- Laura CsereTampa$72
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.